Knoll Capital Management, LLC — 13F Holdings & Portfolio

CIK 1325083 · latest 13F-HR filed 2026-05-15

Knoll Capital Management, LLC manages $180.2M in 13F-reported U.S. long-equity assets across 37 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are Biohaven Pharmactl Hldg Co (10.93%), PHYS (7.61%), RGLD (7.45%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 8 new positions, exited 4, added to 16, and trimmed 10.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$180.2M

Long-equity book

Holdings

37

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+8 / −4 / ↑16 / ↓10

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Franco Nev Corp$2.7M +52.6%
  • Triple Flag Precious Metals$2.0M +104.4%
  • SSR Mining In$1.8M +34.1%
  • Agnico Eagle Mines Ltd$1.8M +19.7%
  • Elicio Therapeutics Inc$1.7M +34.3%
Show all 16

Top Trims

  • Aldeyra Therapeutics Inc-$19.1M -67.4%
  • Nuvation Bio Inc-$7.0M -52.1%
  • Biohaven Pharmactl Hldg Co-$6.6M -25.1%
  • Entera Bio Ltd-$4.9M -43.3%
  • Altimmune Inc-$3.6M -87.8%
Show all 10

New Positions

  • Sprott physical gold Trust$13.7M
  • Sprott Physical silver Trust$5.4M
  • Gold RTY Corp$3.6M
  • Elemental RTY Corp$943.0K
  • Versamet Royalties Corp$633.6K
Show all 8

Exited Positions

  • Avadel Pharmaceuticals Plc$12.9M
  • SPDR Gold Trust$12.7M
  • iShares Silver Trust$5.2M
  • Applied Therapeutics Inc$605.0K
Show all 4
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Biohaven Pharmactl Hldg Co G11196105 $19.7M 10.93% 2,328,602 SH
2 Sprott physical gold Trust PHYS 85207H104 $13.7M 7.61% 387,055 SH
3 Royal Gold Inc. RGLD 780287108 $13.4M 7.45% 52,750 SH
4 MeiraGTX Holdings MGTX G59665102 $10.8M 6.01% 1,250,000 SH
5 Agnico Eagle Mines Ltd AEM 008474108 $10.7M 5.94% 52,750 SH
6 Kinross Gold Corp KGC 496902404 $9.8M 5.42% 320,000 SH
7 Aldeyra Therapeutics Inc ALDX 01438T106 $9.3M 5.14% 5,475,516 SH
8 SEABRIDGE GOLD INC SA 811916105 $9.0M 4.99% 317,003 SH
9 Franco Nev Corp FNV 351858105 $7.9M 4.39% 32,000 SH
10 SSR Mining In SSRM 784730103 $7.2M 4.00% 245,000 SH
11 Elicio Therapeutics Inc ELTX 28657F103 $6.7M 3.74% 630,915 SH
12 Entera Bio Ltd ENTX M40527109 $6.5M 3.59% 5,881,879 SH
13 Nuvation Bio Inc NUVB 67080N101 $6.4M 3.57% 1,498,591 SH
14 Centerra Gold Inc CGAU 152006102 $6.4M 3.54% 359,000 SH
15 Pan American Silver PAAS 697900108 $5.5M 3.03% 100,035 SH
16 Sprott Physical silver Trust PSLV 85207K107 $5.4M 3.01% 222,160 SH
17 Ocular Therapeutix Inc. OCUL 67576A100 $5.1M 2.82% 600,400 SH
18 Triple Flag Precious Metals TFPM 89679M104 $4.0M 2.22% 115,000 SH
19 Gold RTY Corp GROY 38071H106 $3.6M 1.99% 1,000,000 SH
20 Alamos Gold Inc AGI 011532108 $2.2M 1.23% 50,000 SH
21 Abeona Therapeutics ABEO 00289Y206 $2.2M 1.21% 485,515 SH
22 New Pac Metals Corp NEWP 64782A107 $2.0M 1.11% 485,000 SH
23 Coeur Mining Inc CDE 192108504 $1.8M 1.00% 96,132 SH
24 iSHares US Aerospace & Defense ITA 464288760 $1.7M 0.93% 7,650 SH
25 Philip Morris Intl. Inc PM 718172109 $1.7M 0.92% 10,000 SH
26 Wheaton Precious Metals Corp WPM 962879102 $1.6M 0.91% 12,500 SH
27 Northrop Grumman Corp NOC 666807102 $1.5M 0.82% 2,165 SH
28 Booz Allen Hamilton HLDG COR BAH 099502106 $1.0M 0.56% 13,000 SH
29 Elemental RTY Corp ELE 28620K106 $943.0K 0.52% 50,000 SH
30 Versamet Royalties Corp VMET 92528V200 $633.6K 0.35% 66,621 SH
31 Dakota Gold Corp DC 46655E100 $620.8K 0.34% 122,921 SH
32 Amrize LTD AMRZ H2927K103 $514.0K 0.29% 9,175 SH
33 Altimmune Inc ALT 02155H200 $492.8K 0.27% 160,000 SH
34 Cardiol Therapeutics Inc CRDL 14161Y200 $135.0K 0.07% 100,000 SH
35 Pharming Group NV PHAR 71716E105 $67.5K 0.04% 4,057 SH
36 Orgenesis, Inc. ORGS 68619K105 $30.4K 0.02% 50,623 SH
37 OR Royalties OR 68390D106 $8.6K 0.00% 225,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $180.2M 37 0001104659-26-062445
2025-12-31 2026-02-17 $218.0M 34 0001104659-26-016376
2025-09-30 2025-11-14 $186.6M 39 0001104659-25-112578